Epilepsy Drugs Market by Type, Etiology, Age of Onset, and Geography - Forecast and Analysis 2020-2024

Executive Summary

Market Landscape

• Market ecosystem
• Market characteristics
• Value chain analysis

Market Sizing

• Market definition
• Market segment analysis
• Market size 2019
• Market outlook: Forecast for 2019 - 2024

Five Forces Analysis

• Five forces summary
• Bargaining power of buyers
• Bargaining power of suppliers
• Threat of new entrants
• Threat of substitutes
• Threat of rivalry
• Market condition

Market Segmentation by Type

• Market segments
• Comparison by Type
• Narrow spectrum drugs - Market size and forecast 2019-2024
• Broad spectrum drugs - Market size and forecast 2019-2024
• Market opportunity by Type

Segmentation by Etiology

• Genetic etiology
• Structural etiology
• Metabolic etiology
• Immune etiology
• Infectious etiology
• Unknown etiology

Segmentation by Age of Onset

• Neonatal/infantile
• Childhood
• Adolescents/adults
• Variable age

Customer landscape

Geographic Landscape

• Geographic segmentation
• Geographic comparison
• North America - Market size and forecast 2019-2024
• Europe - Market size and forecast 2019-2024
• Asia - Market size and forecast 2019-2024
• ROW - Market size and forecast 2019-2024
• Key leading countries
• Market opportunity by geography
• Market drivers
• Market challenges
• Market trends

Vendor Landscape

• Vendor landscape
• Landscape disruption
• Competitive Scenario

Vendor Analysis

• Vendors covered
• Market positioning of vendors
• Abbott Laboratories
• Eisai Co. Ltd.
• GlaxoSmithKline Plc
• Johnson & Johnson
• Mylan NV
• Novartis AG
• Pfizer Inc.
• Sanofi
• Teva Pharmaceutical Industries Ltd.
• UCB SA

Appendix

• Scope of the report
• Currency conversion rates for US$
• Research methodology
• List of abbreviations